IDEXX beats expectations on Q3 earnings, citing ‘strong recovery’ in pet health care

IDEXX Laboratories Inc. (Nasdaq: IDXX) on Thursday posted third-quarter results that beat market expectations amid a strong performance in its pet diagnostics business.

The Westbrook-based provider of veterinary diagnostics, veterinary practice software and water microbiology testing reported Q3 earnings of $1.69 per diluted share, or 27 cents a share above a consensus forecast reported by financial news site Seeking Alpha.

Compared to a year ago, earnings per share were 36% higher on a reported basis and 47% higher on a comparable currency basis. Read more

Related Posts

Business Leaders: Deborah Bronk steers Bigelow Lab expansion to boost reach, programming

Deborah Bronk is president, CEO and a senior research scientist at Bigelow Laboratory for Ocean Sciences in East Boothbay, which will...

24 March 2025

UNE retains R2 Research status, reinforcing leadership in scientific advancement

The University of New England has retained its status as one of the country’s leading research universities with the recent release...

23 March 2025

Maine college students investigate health effects of forever chemicals

Two dozen Maine college students are investigating the public health effects of forever chemicals by using zebrafish as human stand-ins and...

21 March 2025